2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
April 15th, 2025
Version: 1
Department of Surgery, Section for Translational Surgical Oncology and Biobanking, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck
cancer biology
biorxiv

Proteomic Remodeling During Tumor Cell-Induced Platelet Aggregation Unveils Metastatic Drivers in Colorectal Cancer

Sauer, T.Open in Google Scholar•Gruner, C.Open in Google Scholar•Kern, K.Open in Google Scholar•Rackisch, A.Open in Google Scholar•Tischner, L.Open in Google Scholar•Schulz, K.Open in Google Scholar•Ostermann, J.Open in Google Scholar•Cohrs, L.Open in Google Scholar•Kohl, M.Open in Google Scholar•Verschoor, A.Open in Google Scholaret al.

Background: Colorectal cancer (CRC) is frequently associated with metastasis, resulting in high mortality rates. Platelets are known to play a crucial role in the metastatic cascade influencing tumor microenvironment remodeling, promoting cell transformation, facilitating metastatic niche formation, and shielding circulating tumor cells from immune surveillance. However, platelet proteomic alterations during tumor cell-induced platelet aggregation (TCIPA) remain largely unexplored. This study aims to characterize the proteomic profile of TCIPA in CRC using an in vitro model that recapitulates key aspects of CRC metastasis. Methods: TCIPA was assessed via light transmission aggregometry using an in vitro model incorporating paired primary and metastatic cell cultures. Stable Isotope Labeling with Amino Acids in Cell culture (SILAC) allowed for the discrimination of healthy platelet and tumor cell proteomes prior to and following TCIPA. Data-independent acquisition mass spectrometry was employed to analyze intra- and extracellular tumor and platelet proteomes. Comparative proteomic profiling was performed using a range of bioinformatic analyses, including clustering, differential expression, and Gene Set Enrichment Analyses (GSEA). Results: Comparison of the baseline proteome profiles of the CRC cell lines SW480 and SW620 identified 263 significant differentially expressed proteins (FDR [≤] 0.05, log2FC [≥] 1). The GSEA demonstrated enrichment of the \'epithelial-mesenchymal transition \' (FDR: 5.617 x 10-5) gene set in SW480 cells. While SW480 exhibited rapid TCIPA, SW620 did not consistently interact with healthy platelets. Following TCIPA, 34 tumor proteins showed differential expression compared to their naive status (without platelet-exposure). Notably, 17 of these proteins were significantly associated with CRC progression, particularly in the promotion of EMT, metastasis, tumor cell survival, proliferation, and metabolic reprogramming. Conclusions: This study successfully characterized the proteomic profiles of platelets, platelet secretomes, and colorectal tumor cells following TCIPA-induced activation. The findings highlight the significant role of several tumor proteins and their metabolic effects in colorectal cancer progression, particularly with regard to metastasis.

Similar Papers

biorxiv
Wed Apr 16 2025
A mathematical model for cancer dynamics with treatment and saboteur bacteria
We construct a mathematical model of cancer dynamics with chemotherapeutic treatment, in the presence of bacteria that are capable of metabolizing the chemotherapeutic drug, hence sabotaging the treatment. We investigate the possibility of complementing the cancer treatment with antibiotic drugs, thus eradicating the bacteria or at least mitigating their negative impact on the prospects of therapy...
Geretovszky, A.
•
Röst, G.
biorxiv
Wed Apr 16 2025
Amino acid restriction sensitizes lung cancer cells toferroptosis via GCN2-dependent activation of the integratedstress response
Lung cancer cells are vulnerable to iron-dependent oxidation of phospholipids leading to ferroptosis, a process countered by glutathione peroxidase-4 that converts lipid hydroperoxides to lipid alcohols using glutathione as reducing agent. Since ferroptosis-inducing agents are in clinical development, identifying modifiers of ferroptosis susceptibility is warranted. Here, we investigate the impact...
Garrelick, V. J.
•
Gul, N.
•
Horrieh, P.
•
Mustafa, D.
...•
Lindahl, P.
biorxiv
Tue Apr 15 2025
The carnosinase dipeptidase CNDP1 is a novel metabolic vulnerability in brain metastasis
Brain metastatic cells undergo metabolic adaptations, such as increased reliance on oxidative phosphorylation. Integrating proteomic and transcriptomic profiling of patient samples revealed a consistent upregulation of the carnosine dipeptidase-1 (CNDP1) in brain versus extracranial metastases. Carnosine is an abundant metabolite in brain and muscle, known to exert anti-proliferative effects on ca...
Gomez-Munoz, M. A.
•
Karz, A.
•
Navarro, M.
•
Osorio-Vasquez, V. M.
...•
Hernando, E.
biorxiv
Tue Apr 15 2025
Splice-switching ASOs targeting an Alu-derived exon in the AURKA 5'UTR collapse an SRSF1-AURKA-MYC oncogenic circuit in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy, driven by oncogenic KRAS mutations and dysregulated oncogenes, such as SRSF1, MYC, and AURKA. Although KRAS-targeted therapies are in development, resistance mechanisms underscore the need to identify alternative vulnerabilities. Here, we uncover an SRSF1-AURKA-MYC oncogenic circuit, wherein SRSF1 regulates AURKA 5\'UTR al...
Kral, A. J.
•
Jia, L.
•
Sim, G.
•
Wan, L.
•
Krainer, A. R.
biorxiv
Tue Apr 15 2025
A Dual-Action Liposome-Peptide Formulation Synergistically Counteracts A Gain-of-Function p53 Mutant
Objective. Inactivation of p53 tumor suppressor functions, often through missense mutations, is essential for carcinogenesis. A sub-class of such p53 missense mutations gains new functions, including drug resistance and enhanced proliferation, in addition to its loss of function. Among the most frequent gain-of-function p53 mutants, R273H occurs in tumors of many tissue origins and imparts aggress...
Ghosh Chaudhary, S.
•
Bhowmick, S.
•
Bhattacharya, S.
•
Roy, S.
•
Ali, N.
biorxiv
Tue Apr 15 2025
The E3 ligase HECTD4 regulates COX-2 dependent tumor progression and metastasis
E3 ubiquitin ligases mediating turnover of proteins engaged in cancer progression point to key regulatory nodes. To uncover modifiers of metastatic competency, we conducted an in vivo genome-wide CRISPR-inactivation screen using cultured breast circulating tumor cells, following intravascular seeding and lung colonization. We identified HECTD4, a previously uncharacterized gene encoding a conserve...
Vuille, J. A.
•
Tanriover, C.
•
Micalizzi, D. S.
•
Ebright, R. Y.
...•
Haber, D. A.
biorxiv
Tue Apr 15 2025
Quantifying replication stress in cancer without proliferation confounding
Replication stress (RS) is a major driver of genomic instability and cancer development, caused by impaired DNA replication that can lead to chromosomal instability (CIN). Although RS is mechanistically linked to CIN, its relationship with cellular proliferation is complex. Depending on the context, RS can either promote or suppress cell growth. Existing RS gene expression signatures overlook this...
Jungk, P.
•
Kschischo, M.
biorxiv
Tue Apr 15 2025
Tumoral CD24 tunes platelets binding and pro-metastatic functions
One of the earliest steps of breast cancer metastasis occurs when tumor cells (TCs) disseminate through the bloodstream. There, they interact with several blood components. Among them, platelet favor TC survival and metastatic spread. While the binding of platelet to TC is highly variable, its molecular controls and downstream consequences remain unidentified. Here, we first document that high CD2...
Mittelheisser, V.
•
Liboni, C.
•
Mouriaux, C.
•
Trivigno, S. M. G.
...•
GOETZ, J. G.
biorxiv
Tue Apr 15 2025
Molecular insights into early malignant transition of hepatocellular carcinoma
The molecular continuum of premalignant-to-malignant transition remains elusive in carcinogenesis, primarily due to the difficulty in sampling transitional lesions. Here, we present comprehensive genomic and immunological profiling of 21 very early hepatocellular carcinomas (veHCCs) arising within 17 cancer-prone DNs. Surprisingly, 82% of cancer-prone DNs harbored TERT alterations, suggesting a pr...
Hui, L.
•
Zhang, Z.
•
Li, H.
•
Chen, L.
...•
Ji, Y.